Austrian firm BIA Separations and The Centre for Bio Separations Technology (CBST) at India’s VIT University are combining their expertise to develop new bioseparation platforms and technologies, and establish a BioSeparations Platform of Excellence at CBST, which will offer technical support, contract research, and services to the biopharmaceutical industry.
CBST/VIT says teaming up with BIA will give it access to leading-edge technologies and expertise in the field of downstream purification and separation of large biomolecules, which will complement its own scientific and research capabilities to help bridge the gap between industry and academia in the bioseparations field. From the BIA perspective the partnership will not only bring benefits to the biopharmaceutical and academic sectors globally, but will also provide the firm with the opportunity to establish an Indian operation.
CBST/VIT was established in 2005 by the Indian government as a center of excellence in bioseparation technologies, spearheading innovative research, with state-of-the-art technologies and multidisciplinary approaches, research, and training. The facility is focused primarily on therapeutics, and has specialist expertise protein expression, purification, and validation.
A key goal of the center is to train Indian scientists and disseminate knowledge in the field of bioseparation technologies, which it claims is limiting factor in value-added biomolecules production. To this end CBST offers training in biomolecule production, including protein expression, monoclonal antibody production, and the production and purification of other bioactive molecules.
BIA Separations manufactures the CIM Convective Interaction Media® short monolithic chromatographic columns, which are optimized for the separation and purification of large biomolecules and viral particles on a laboratory and industrial scale.